The DOI matches its Crossref record; 56 of the 56 references it cites were found in a registry or an index.
Molecular Signature of CD8+ T Cell Exhaustion during Chronic Viral Infection
Open accessAbstract
Chronic viral infections often result in T cell exhaustion. To determine the molecular signature of exhaustion, we compared the gene-expression profiles of dysfunctional lymphocytic choriomeningitis virus (LCMV)-specific CD8(+) T cells from chronic infection to functional LCMV-specific effector and memory CD8(+) T cells generated after acute infection. These data showed that exhausted CD8(+) T cells: (1) overexpressed several inhibitory receptors, including PD-1, (2) had major changes in T cell receptor and cytokine signaling pathways, (3) displayed altered expression of genes involved in chemotaxis, adhesion, and migration, (4) expressed a distinct set of transcription factors, and (5) had profound metabolic and bioenergetic deficiencies. T cell exhaustion was progressive, and gene-expression profiling indicated that T cell exhaustion and anergy were distinct processes. Thus, functional exhaustion is probably due to both active suppression and passive defects in signaling and metabolism. These results provide a framework for designing rational immunotherapies during chronic infections.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“T cells acquiring multiple inhibitory surface molecules in persistent disease settings such as chronic infection [37,38] and malignancies [30,**39,40], which effectively prevent T cell activation.”
From T cell anergy, exhaustion, senescence, and stemness in the tumor microenvironment (2013) · cites this paper as [37]
In the citing paper
“Secretion of TNF-α in some populations of cells is reduced because of the contemporary arrest of p38-MAPK and PD-1 pathways.”
From Immunosenescence and Its Hallmarks: How to Oppose Aging Strategically? A Review of Potential Options for Therapeutic Intervention (2019) · cites this paper as [194]
In the citing paper
“However, the telomerase activity in CD8+/CD45RA+ T cells is improved by blocking only the p38 pathway but not the PD-1 signaling, indicating that non-overlapping signaling pathways are involved (193, 194).”
From Immunosenescence and Its Hallmarks: How to Oppose Aging Strategically? A Review of Potential Options for Therapeutic Intervention (2019) · cites this paper as [194]
In the citing paper
“In these cells that present characteristics of immune senescence (decreased proliferation, lower telomerase activity, and increased presence of DNA damage), the simultaneous blockade of both p38-MAPK and PD-1 signaling supports their proliferation, both in young and in older human beings.”
From Immunosenescence and Its Hallmarks: How to Oppose Aging Strategically? A Review of Potential Options for Therapeutic Intervention (2019) · cites this paper as [194]
Citations
Cites
Subramanian, A., Tamayo, P., Mootha, V. K., Mukherjee, S., Ebert, B. L., Gillette, M. A., Paulovich, A., Pomeroy, S. L., Golub, T. R., Lander, E. S., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506580102 · Cited by 53,625
Restoring function in exhausted CD8 T cells during chronic viral infection
Barber, D. L., Wherry, E. J., Masopust, D., Zhu, B., Allison, J. P., Sharpe, A. H., Freeman, G. J., & Ahmed, R. (2005) · Nature · doi:10.1038/nature04444 · Cited by 4,057
Self-citationPD-1 expression on HIV-specific T cells is associated with T-cell exhaustion and disease progression
Day, C. L., Kaufmann, D. E., Kiepiela, P., Brown, J. A., Moodley, E. S., Reddy, S., Mackey, E. W., Miller, J. D., Leslie, A. J., DePierres, C., et al. (2006) · Nature · doi:10.1038/nature05115 · Cited by 2,680
Self-citationGreenwald, R. J., Freeman, G. J., & Sharpe, A. H. (2005) · Annual Review of Immunology · doi:10.1146/annurev.immunol.23.021704.115611 · Cited by 2,318
Viral Immune Evasion Due to Persistence of Activated T Cells Without Effector Function
Zajac, A. J., Blattman, J. N., Murali-Krishna, K., Sourdive, D. J. D., Suresh, M., Altman, J. D., & Ahmed, R. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.188.12.2205 · Cited by 1,978
Self-citationCTLA-4 and PD-1 Receptors Inhibit T-Cell Activation by Distinct Mechanisms
Parry, R. V., Chemnitz, J. M., Frauwirth, K. A., Lanfranco, A. R., Braunstein, I., Kobayashi, S. V., Linsley, P. S., Thompson, C. B., & Riley, J. L. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.21.9543-9553.2005 · Cited by 1,931
Joshi, N. S., Cui, W., Chandele, A., Lee, H. K., Urso, D. R., Hagman, J., Gapin, L., & Kaech, S. M. (2007) · Immunity · doi:10.1016/j.immuni.2007.07.010 · Cited by 1,861
Self-citationWherry, E. J., Blattman, J. N., Murali‐Krishna, K., der Most, R. G. V., & Ahmed, R. (2003) · Journal of Virology · doi:10.1128/jvi.77.8.4911-4927.2003 · Cited by 1,645
Self-citationLanier, L. L. (1998) · Annual Review of Immunology · doi:10.1146/annurev.immunol.16.1.359 · Cited by 1,641
Upregulation of PD-1 expression on HIV-specific CD8+ T cells leads to reversible immune dysfunction
Trautmann, L., Janbazian, L., Chomont, N., Said, E. A., Gimmig, S., Bessette, B., Boulassel, M.-R., Delwart, E., Sepulveda, H., Balderas, R. S., et al. (2006) · Nature Medicine · doi:10.1038/nm1482 · Cited by 1,565
Flagged first, then by citations
Cited by
Sorted by citations
Items 801–900 of 1,007
Zhou, L., Adrianto, I., Wang, J., Wu, X., Datta, I., & Mi, Q. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.00384 · Cited by 50
Protective CD8 T Cell Memory Is Impaired during Chronic CD70-Driven Costimulation
van Gisbergen, K. P. J. M., van Olffen, R. W., van Beek, J., van der Sluijs, K. F., Arens, R., Nolte, M. A., & van Lier, R. A. W. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0802809 · Cited by 47
Revisiting Estimates of CTL Killing Rates In Vivo
Yates, A. J., Graw, F., Barber, D. L., Ahmed, R., Regoes, R. R., & Antia, R. (2007) · PLoS ONE · doi:10.1371/journal.pone.0001301 · Cited by 48
Self-citationTumors and Cytomegalovirus: An Intimate Interplay
Herbein, G. (2022) · Viruses · doi:10.3390/v14040812 · Cited by 47
Zhu, L., Zhou, X., Gu, M., Kim, J., Li, Y., Ko, C., Xie, X., Gao, T., Cheng, X., & Sun, S. (2022) · Nature Cell Biology · doi:10.1038/s41556-022-00942-8 · Cited by 46
Signature profiles of CMV-specific T-cells in patients with CMV reactivation after hematopoietic SCT
Król, L., Stuchlý, J., Hubáček, P., Keslová, P., Sedláček, P., Starý, J., Hrušák, O., & Kalina, T. (2010) · Bone Marrow Transplantation · doi:10.1038/bmt.2010.261 · Cited by 47
Adaptive immune response to viral infections in the central nervous system
Libbey, J. E., & Fujinami, R. S. (2014) · Handbook of clinical neurology · doi:10.1016/b978-0-444-53488-0.00010-9 · Cited by 47
Immune Checkpoint Function of CD85j in CD8 T Cell Differentiation and Aging
Gustafson, C. E., Qi, Q., Hutter-Saunders, J. A. L., Gupta, S., Jadhav, R. R., Newell, E. W., Maecker, H. T., Weyand, C. M., & Goronzy, J. J. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00692 · Cited by 51
A Threshold Model for T-Cell Activation in the Era of Checkpoint Blockade Immunotherapy
Guram, K., Kim, S. S., Wu, V. H., Sanders, P. D., Patel, S. H., Schoenberger, S. P., Cohen, E. E. W., Chen, S., & Sharabi, A. B. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00491 · Cited by 51
Martínez-Usatorre, A., Sempere, L. F., Carmona, S. J., Carretero-Iglesia, L., Monnot, G., Speiser, D. E., Rufer, N., Donda, A., Zehn, D., Jandus, C., et al. (2019) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-18-0504 · Cited by 50
Solman, I. G., Blum, L. K., Burger, J. A., Kipps, T. J., Dean, J. P., James, D. F., & Mongan, A. M. (2021) · Leukemia Research · doi:10.1016/j.leukres.2021.106520 · Cited by 47
Making memories that last a lifetime: heritable functions of self-renewing memory CD8 T cells
Youngblood, B., Davis, C. W., & Ahmed, R. (2010) · International Immunology · doi:10.1093/intimm/dxq437 · Cited by 49
Self-citationIL-10: Achieving Balance During Persistent Viral Infection
Ng, C. T., & Oldstone, M. B. A. (2014) · Current topics in microbiology and immunology · doi:10.1007/978-3-662-43492-5_6 · Cited by 53
Lucas, C. L., Workman, C. J., Beyaz, S., LoCascio, S. A., Zhao, G., Vignali, D. A. A., & Sykes, M. (2011) · Blood · doi:10.1182/blood-2010-11-318675 · Cited by 46
Adaptive response in hepatitis B virus infection
Loggi, E., Gamal, N., Bihl, F. K., Bernardi, M., & Andreoné, P. (2014) · Journal of Viral Hepatitis · doi:10.1111/jvh.12255 · Cited by 48
Clouthier, D., Zhou, A. C., Wortzman, M. E., Luft, O., Levy, G. A., & Watts, T. H. (2015) · PLoS Pathogens · doi:10.1371/journal.ppat.1004517 · Cited by 47
Garidou, L., Heydari, S., Gossa, S., & McGavern, D. B. (2012) · Journal of Virology · doi:10.1128/jvi.00164-12 · Cited by 46
IL-4 Induced Innate CD8+ T Cells Control Persistent Viral Infection
Lee, A., Park, S. P., Park, C. H., Kang, B. H., Park, S. H., Ha, S., & Jung, K. C. (2015) · PLoS Pathogens · doi:10.1371/journal.ppat.1005193 · Cited by 46
Self-citationNguyen, H. H., Kim, T., Song, S. Y., Park, S., Cho, H. H., Jung, S., Ahn, J., Kim, H., Lee, J., Kim, H.-O., et al. (2016) · Scientific Reports · doi:10.1038/srep28208 · Cited by 47
Transcriptional and epigenetic regulation of T cell hyporesponsiveness
Pereira, R. M., Hogan, P. G., Rao, A., & Martínez, G. (2017) · Journal of Leukocyte Biology · doi:10.1189/jlb.2ri0317-097r · Cited by 50
Composite CD79A/CD40 co-stimulatory endodomain enhances CD19CAR-T cell proliferation and survival
Julamanee, J., Terakura, S., Umemura, K., Adachi, Y., Miyao, K., Okuno, S., Takagi, E., Sakai, T., Koyama, D., Goto, T., et al. (2021) · Molecular Therapy · doi:10.1016/j.ymthe.2021.04.038 · Cited by 47
Secondary infections rejuvenate the intestinal CD103+tissue-resident memory T cell pool
von Hoesslin, M., Kuhlmann, M., de Almeida, G. P., Kanev, K., Wurmser, C., Gerullis, A.-K., Roelli, P., Berner, J., & Zehn, D. (2022) · Science Immunology · doi:10.1126/sciimmunol.abp9553 · Cited by 44
Mylvaganam, G., Velu, V., Hong, J., Sadagopal, S., Kwa, S., Basu, R., Lawson, B., Villinger, F. J., & Amara, R. R. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1401222 · Cited by 45
Inhibitory TCR Coreceptor PD-1 Is a Sensitive Indicator of Low-Level Replication of SIV and HIV-1
Salisch, N. C., Kaufmann, D., Awad, A. S., Reeves, R. K., Tighe, D. P., Li, Y., Piatak, M., Lifson, J. D., Evans, D. T., Pereyra, F., et al. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0902781 · Cited by 45
O’Connell, A. E., Volpi, S., Dobbs, K., Fiorini, C., Tsitsikov, E. N., de Boer, H., Barlan, I. B., Despotovic, J. M., Espinosa-Rosales, F. J., Hanson, I. C., et al. (2014) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00340 · Cited by 47
Dauby, N., Kummert, C., Lecomte, S., Liesnard, C., Delforge, M., Donner, C., & Marchant, A. (2014) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiu255 · Cited by 45
Acute Viral Respiratory Infection Rapidly Induces a CD8+ T Cell Exhaustion–like Phenotype
Erickson, J. J., Wang, L., Wen, S. C., Hastings, A. K., Gilchuk, P., Joyce, S., Shyr, Y., & Williams, J. V. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1403004 · Cited by 48
Aparicio‐Domingo, P., Cannelle, H., Buechler, M. B., Nguyen, S., Kallert, S. M., Favre, S., Alouche, N., Papazian, N., Ludewig, B., Cupedo, T., et al. (2020) · European Journal of Immunology · doi:10.1002/eji.201948413 · Cited by 44
The Impact of Malaria Parasites on Dendritic Cell–T Cell Interaction
Osii, R., Otto, T. D., Garside, P., Ndungu, F. M., & Brewer, J. M. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01597 · Cited by 49
Revisiting T Cell Tolerance as a Checkpoint Target for Cancer Immunotherapy
Nüssing, S., Trapani, J. A., & Parish, I. A. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.589641 · Cited by 48
Molecular and Clinical Characterization of LAG3 in Breast Cancer Through 2994 Samples
Liu, Q., Qi, Y., Zhai, J., Kong, X., Wang, X., Wang, Z., Fang, Y., & Wang, J. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.599207 · Cited by 45
Schrödinger’s T Cells: Molecular Insights Into Stemness and Exhaustion
Gonzalez, N. M., Zou, D., Gu, A., & Chen, W. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.725618 · Cited by 46
Exhausted T cells hijacking the cancer-immunity cycle: Assets and liabilities
Brunell, A. E., Lahesmaa, R., Autio, A. K., & Thotakura, A. K. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1151632 · Cited by 46
Palermo, B., Franzese, O., Frisullo, G., D’Ambrosio, L., Panetta, M., Campo, G., D’Andrea, D., Sperduti, I., Nicola, F. D., Goeman, F., et al. (2023) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-023-02846-3 · Cited by 46
Baker, K. F., McDonald, D., Hulme, G., Hussain, R., Coxhead, J., Swan, D. J., Schulz, A. R., Mei, H. E., MacDonald, L., Pratt, A. G., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-45213-2 · Cited by 48
HIV-Specific CD8+T Cells from Elite Controllers Are Primed for Survival
Yan, J., Sabbaj, S., Bansal, A., Amatya, N., Shacka, J. J., Goepfert, P., & Heath, S. L. (2013) · Journal of Virology · doi:10.1128/jvi.02379-12 · Cited by 43
Functional profile of S100A4‐deficient T cells
Weatherly, K., Bettonville, M., Torres, D., Köhler, A., Goriely, S., & Braun, M. Y. (2015) · Immunity Inflammation and Disease · doi:10.1002/iid3.85 · Cited by 44
Pronounced Virus-Dependent Activation Drives Exhaustion but Sustains IFN-γ Transcript Levels
Mackerness, K., Cox, M. A., Lilly, L. M., Weaver, C. T., Harrington, L. E., & Zajac, A. J. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.1000841 · Cited by 44
Anichini, A., Tassi, E., Grazia, G., & Mortarini, R. (2018) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-018-2147-7 · Cited by 45
Immune Exhaustion: Past Lessons and New Insights from Lymphocytic Choriomeningitis Virus
Kahan, S. M., & Zajac, A. J. (2019) · Viruses · doi:10.3390/v11020156 · Cited by 44
Type I IFNs and CD8 T cells increase intestinal barrier permeability after chronic viral infection
Labarta-Bajo, L., Nilsen, S. P., Humphrey, G., Schwartz, T., Sanders, K., Swafford, A. D.-E., Knight, R. D., Turner, J. R., & Zúñiga, E. I. (2020) · The Journal of Experimental Medicine · doi:10.1084/jem.20192276 · Cited by 42
Mason, N. J., Chester, N., Xiong, A., Rotolo, A., Wu, Y., Yoshimoto, S., Glassman, P. M., Gulendran, G., & Siegel, D. L. (2021) · mAbs · doi:10.1080/19420862.2021.2004638 · Cited by 44
Billingsley, J. M., Rajakumar, P. A., Connole, M., Salisch, N. C., Adnan, S., Kuzmichev, Y. V., Hong, H. S., Reeves, R. K., Kang, H., Li, W., et al. (2015) · PLoS Pathogens · doi:10.1371/journal.ppat.1004740 · Cited by 47
Zhu, H., Yang, S.-H., Gao, C., Bian, Z.-H., Chen, X.-M., Huang, R., Meng, Q.-L., Li, X., Jin, H., Tsuneyama, K., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-46654-5 · Cited by 43
New insights into type I interferon and the immunopathogenesis of persistent viral infections
Snell, L. M., & Brooks, D. G. (2015) · Current Opinion in Immunology · doi:10.1016/j.coi.2015.03.002 · Cited by 43
Vanders, R. L., Gibson, P. G., Murphy, V. E., & Wark, P. A. B. (2013) · The Journal of Infectious Diseases · doi:10.1093/infdis/jit296 · Cited by 43
Ataxia Telangiectasia Mutated Kinase Controls Chronic Gammaherpesvirus Infection
Kulinski, J. M., Leonardo, S. M., Mounce, B. C., Malherbe, L. P., Gauld, S. B., & Tarakanova, V. L. (2012) · Journal of Virology · doi:10.1128/jvi.00917-12 · Cited by 43
Maturational characteristics of HIV-specific antibodies in viremic individuals
Meffre, E., Louie, A., Bannock, J. M., Kim, L. J. Y., Ho, J., Frear, C. C., Kardava, L., Wang, W., Buckner, C. M., Wang, Y., et al. (2016) · JCI Insight · doi:10.1172/jci.insight.84610 · Cited by 39
Jaular, L. M., Menezes‐Neto, A., Tortajada, M., Elizalde‐Torrent, A., Díaz-Varela, M., Fernández-Becerra, C., Borràs, F. E., Montoya, M., & Portillo, H. A. D. (2016) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2016.00131 · Cited by 43
Smoking activates cytotoxic CD8+ T cells and causes survivin release in rheumatoid arthritis
Wasén, C., Turkkila, M., Bossios, A., Erlandsson, M. C., Andersson, K., Ekerljung, L., Malmhäll, C., Brisslert, M., Silfverswärd, S. T., Lundbäck, B., et al. (2017) · Journal of Autoimmunity · doi:10.1016/j.jaut.2016.12.009 · Cited by 43
Herold, K. C., Bucktrout, S. L., Wang, X., Bode, B. W., Gitelman, S. E., Gottlieb, P. A., Hughes, J. W., Joh, T., McGill, J. B., Pettus, J., et al. (2019) · JCI Insight · doi:10.1172/jci.insight.126054 · Cited by 43
Hu, D., Tjon, E. C., Andersson, K., Molica, G. M., Pham, M. C., Healy, B. C., Murugaiyan, G., Pochet, N. L. M. M., Kuchroo, V. K., Bokarewa, M. I., et al. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2007935117 · Cited by 43
Hokey, D. A., Johnson, F. B., Smith, J. S., Weber, J., Yan, J., Hirao, L. A., Boyer, J., Lewis, M. G., Makedonas, G., Betts, M. R., et al. (2008) · European Journal of Immunology · doi:10.1002/eji.200737857 · Cited by 42
Reversal of functional defects in highly differentiated young and old CD8 T cells by PDL blockade
Henson, S. M., Macaulay, R., Franzese, O., & Akbar, A. N. (2012) · Immunology · doi:10.1111/j.1365-2567.2011.03550.x · Cited by 42
Kursunel, M. A., Taşkıran, E. Z., Tavukçuoğlu, E., Yanık, H., Demirağ, F., Karaosmanoğlu, B., Kurt, F. G. Ö., Üner, A., Esendagli, D. R., Kızılgöz, D., et al. (2021) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-021-02998-1 · Cited by 42
Carlisle, J. W., Jansen, C. S., Cardenas, M. A., Sobierajska, E., Reyes, A. M., Greenwald, R., del Balzo, L., Prokhnevska, N., Küçük, Ö., Carthon, B. C., et al. (2022) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2022-004803 · Cited by 42
Neubert, E. N., DeRogatis, J. M., Lewis, S. A., Viramontes, K. M., Ortega, P., Henriquez, M. L., Buisson, R., Messaoudi, I., & Tinoco, R. (2023) · Nature Communications · doi:10.1038/s41467-023-41352-0 · Cited by 45
The malate shuttle detoxifies ammonia in exhausted T cells by producing 2-ketoglutarate
Weisshaar, N., Ma, S., Ming, Y., Madi, A., Mieg, A., Hering, M., Zettl, F., Möhr, K., ten Bosch, N., Stichling, D., et al. (2023) · Nature Immunology · doi:10.1038/s41590-023-01636-5 · Cited by 43
Kaptein, P., Slingerland, N., Metoikidou, C., Prinz, F., Brokamp, S., Machuca-Ostos, M., de Roo, G., Schumacher, T. N., Yeung, Y. A., Moynihan, K. D., et al. (2024) · Cancer Discovery · doi:10.1158/2159-8290.cd-23-1263 · Cited by 41
Early methionine availability attenuates T cell exhaustion
Sharma, P., Guo, A., Poudel, S., Boada-Romero, E., Verbist, K., Palacios, G., Immadisetty, K., Chen, J., Haydar, D., Mishra, A., et al. (2025) · Nature Immunology · doi:10.1038/s41590-025-02223-6 · Cited by 45
Chen, I.-H., Lai, Y., Wu, C., Chang, Y., Chu, C., Tsai, I., Sun, F., & Lu, Y. (2009) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-009-0753-0 · Cited by 42
Jing, W., Yan, X., Hallett, W. H. D., Gershan, J. A., & Johnson, B. D. (2011) · Blood · doi:10.1182/blood-2010-12-326108 · Cited by 42
Zhang, L., Wang, J., Wei, F., Wang, K., Sun, Q., Yang, F., Jin, H., Zheng, Y., Zhao, H., Wang, L., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.9871 · Cited by 42
Erickson, J. J., Rogers, M. C., Tollefson, S. J., Boyd, K. L., & Williams, J. V. (2016) · The Journal of Immunology · doi:10.4049/jimmunol.1502115 · Cited by 42
Recent Advances in Immunotherapy in Metastatic NSCLC
Bansal, P., Osman, D. I., Gan, G. N., Simon, G. R., & Boumber, Y. (2016) · Frontiers in Oncology · doi:10.3389/fonc.2016.00239 · Cited by 42
Christoffersson, G., Chodaczek, G., Ratliff, S. S., Coppieters, K. T., & von Herrath, M. G. (2018) · Science Immunology · doi:10.1126/sciimmunol.aam6533 · Cited by 42
Carossino, M., Dini, P., Kalbfleisch, T., Loynachan, A. T., Canisso, I. F., Cook, R. F., Timoney, P. J., & Balasuriya, U. B. R. (2019) · PLoS Pathogens · doi:10.1371/journal.ppat.1007950 · Cited by 42
Intoxication With Endogenous Angiotensin II: A COVID-19 Hypothesis
Sfera, A., Osorio, C., Jafri, N., Diaz, E. L., & Maldonado, J. E. C. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01472 · Cited by 42
Wang, X., Peticone, C., Kotsopoulou, E., Göttgens, B., & Calero‐Nieto, F. J. (2021) · OncoImmunology · doi:10.1080/2162402x.2020.1866287 · Cited by 43
Zhang, E., Zhang, X., Liu, J., Wang, B., Tian, Y., Kosinska, A. D., Ma, Z., Xu, Y. Y., Dittmer, U., Roggendorf, M., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0026196 · Cited by 42
Pombo, C., Wherry, E. J., Emma Gostick, D., Price, D. A., & Betts, M. R. (2015) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiv226 · Cited by 41
Self-citationComplementarity-determining region clustering may cause CAR-T cell dysfunction
Sarén, T., Saronio, G., Torrell, P. M., Zhu, X., Thelander, J., Andersson, Y., Hofström, C., Nestor, M., Dimberg, A., Persson, H., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-40303-z · Cited by 43
Penaloza-MacMaster, P., Provine, N., Blass, E., & Barouch, D. (2015) · Journal of Immunology · doi:10.4049/jimmunol.1403237 · Cited by 38
Histone Methyltransferase and Histone Methylation in Inflammatory T-Cell Responses
He, S., Tong, Q., Bishop, D. K., & Zhang, Y. (2013) · Immunotherapy · doi:10.2217/imt.13.101 · Cited by 41
Srivastava, R., Dervillez, X., Khan, A. A., Chentoufi, A. A., Chilukuri, S., Shukr, N., Fazli, Y., Ong, N., Afifi, R. E., Osorio, N., et al. (2016) · Journal of Virology · doi:10.1128/jvi.02450-15 · Cited by 40
Gravelle, P., Do, C., Franchet, C., Müller, S., Obéric, L., Ysebaert, L., Larocca, L. M., Hohaus, S., Calmels, M., Frénois, F.-X., et al. (2016) · OncoImmunology · doi:10.1080/2162402x.2016.1224044 · Cited by 45
DGK-α: A Checkpoint in Cancer-Mediated Immuno-Inhibition and Target for Immunotherapy
Noeßner, E. (2017) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2017.00016 · Cited by 41
Martin, D., Rödel, F., Balermpas, P., Rödel, C. M., & Fokas, E. (2017) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2017.05.001 · Cited by 42
CAR-T cells and combination therapies: What’s next in the immunotherapy revolution?
Ramello, M. C., Haura, E. B., & Abate‐Daga, D. (2017) · Pharmacological Research · doi:10.1016/j.phrs.2017.11.035 · Cited by 42
Human CD4+ CD25+ CD127hi cells and the Th1/Th2 phenotype
Narsale, A. A., Moya, R., & Davies, J. D. (2018) · Clinical Immunology · doi:10.1016/j.clim.2018.01.003 · Cited by 41
Ye, L., Lou, Y., Lu, L., & Fan, X. (2018) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2018.7015 · Cited by 42
Roy, S., Coulon, P.-G. A., Prakash, S., Srivastava, R., Geertsema, R. S., Dhanushkodi, N. R., Lam, C., Nguyen, V., Gorospe, E., Nguyen, A., et al. (2019) · Journal of Virology · doi:10.1128/jvi.00827-19 · Cited by 41
IL-17RA-Signaling Modulates CD8+ T Cell Survival and Exhaustion During Trypanosoma cruzi Infection
Tosello, J., Furlan, C. L. A., Vernengo, F. F., Rodríguez, C., Ramello, M. C., Vesely, M. C. A., Serrán, M. G., Núñez, N. G., Richer, W., Piaggio, E., et al. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02347 · Cited by 40
Common gamma chain cytokines and CD8 T cells in cancer
Shourian, M., Beltra, J., Bourdin, B., & Decaluwe, H. (2019) · Seminars in Immunology · doi:10.1016/j.smim.2019.101307 · Cited by 43
Resident memory T cells in tumor-distant tissues fortify against metastasis formation
Christian, L. S., Wang, L., Lim, B. J. W., Deng, D., Wu, H., Wang, X., & Li, Q.-J. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.109118 · Cited by 39
Huang, H., Shao, L., Chen, Y., Tang, L., Liu, T., Li, J., & Zhu, H. (2021) · Bioengineering & Translational Medicine · doi:10.1002/btm2.10284 · Cited by 41
Protective and detrimental roles of IL-10 in HIV pathogenesis.
Kwon, D. S., & Kaufmann, D. (2010) · PubMed · doi:10.1684/ecn.2010.0201 · Cited by 41
The contribution of epigenetic memory to immunologic memory
Zediak, V. P., Wherry, E. J., & Berger, S. L. (2011) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2011.01.016 · Cited by 41
Self-citationChronic Activation of the Kinase IKKβ Impairs T Cell Function and Survival
Krishna, S., Xie, D., Gorentla, B. K., Shin, J., Gao, J., & Zhong, X. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1102429 · Cited by 43
Kim, T. K., John, L. S. S., Wieder, E., Khalili, J. S., Ma, Q., & Komanduri, K. V. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0902068 · Cited by 41
Zhu, C., Dixon, K. O., Newcomer, K., Gu, G., Xiao, S., Zaghouani, S., Schramm, M. A., Wang, C., Zhang, H., Goto, K., et al. (2021) · Science Advances · doi:10.1126/sciadv.abd2710 · Cited by 40
A variety of ‘exhausted’ T cells in the tumor microenvironment
Nagasaki, J., & Togashi, Y. (2022) · International Immunology · doi:10.1093/intimm/dxac013 · Cited by 43
Alexander, M. R., Dale, B. L., Smart, C. D., Elijovich, F., Wogsland, C. E., Lima, S. M., Irish, J. M., & Madhur, M. S. (2023) · JACC Basic to Translational Science · doi:10.1016/j.jacbts.2022.09.007 · Cited by 42
Landscapes and mechanisms of CD8+ T cell exhaustion in gastrointestinal cancer
Ding, J., Yang, K., Zhou, H., Huang, Y.-F., Li, H., & Zong, Z. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1149622 · Cited by 45
HIV, Inflammation, and Immunometabolism: A Model of the Inflammatory Theory of Disease
Teer, E., Mukonowenzou, N. C., & Essop, M. F. (2025) · Viruses · doi:10.3390/v17060839 · Cited by 45
The CD8 T-cell Road to Immunotherapy of Toxoplasmosis
Bhadra, R., Gigley, J. P., & Khan, I. A. (2011) · Immunotherapy · doi:10.2217/imt.11.68 · Cited by 39
Murine LRBA deficiency causes CTLA‐4 deficiency in Tregs without progression to immune dysregulation
Burnett, D. L., Parish, I. A., Masle‐Farquhar, E., Brink, R. A., & Goodnow, C. C. (2017) · Immunology and Cell Biology · doi:10.1038/icb.2017.50 · Cited by 40
Local and Systemic CD4+ T Cell Exhaustion Reverses with Clinical Resolution of Pulmonary Sarcoidosis
Hawkins, C., Shaginurova, G. I., Shelton, D. A., Herazo‐Maya, J. D., Oswald-Richter, K. A., Rotsinger, J. E., Young, A., Celada, L. J., Kaminski, N., Sevin, C. M., et al. (2017) · Journal of Immunology Research · doi:10.1155/2017/3642832 · Cited by 40
Frimpong, A., Kusi, K. A., Adu‐Gyasi, D., Amponsah, J. A., Ofori, M. F., & Ndifon, W. O. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01345 · Cited by 42
Metadata
- Authors
- Wherry, E. J., Ha, S.-J., Kaech, S. M., Haining, W. N., Sarkar, S., Kalia, V., Subramaniam, S., Blattman, J. N., Barber, D. L., & Ahmed, R.
- Affiliations
- Emory University (US)
- Dana-Farber Cancer Institute (US)
- Corresponding author
- Wherry, E. John
- Ahmed, Rafi
- ORCID
- Venue
- Immunity
- Publisher
- Elsevier BV
- Published
- 2007-10
- Volume
- 27
- Issue
- 4
- Pages
- 670-684
- ISSN
- 1074-7613 (ISSN-L)
- OpenAlex
- W2040353461
- Cited by
- 2,103
- References
- 56
- Citations by year
- 2026: 110 · 2025: 148 · 2024: 140 · 2023: 144 · 2022: 139 · 2021: 180 · 2020: 161 · 2019: 138 · 2018: 119 · 2017: 102 · 2016: 112 · 2015: 116 · 2014: 88 · 2013: 83 · 2012: 80
- FWCI
- 19.12
- Type
- journal article
- Language
- en
- Update notices
- erratum (2007-11-26)
- Open access
- bronze
- doi.org
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- www.elsevier.com/open-access/userlicense/1.0/ (vor, 2116 d)
- doi.org/10.15223/policy-017 (stm-asf)
- doi.org/10.15223/policy-037 (stm-asf)
- doi.org/10.15223/policy-012 (stm-asf)
- doi.org/10.15223/policy-029 (stm-asf)
- doi.org/10.15223/policy-004 (stm-asf)
- Locations
- Immunity (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute of Allergy and Infectious Diseases (AI071309, AI 30048, R01AI071309)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Health Sciences › Medicine › Oncology › Cancer Immunotherapy and Biomarkers
- Life Sciences › Immunology and Microbiology › Immunology › Immune Cell Function and Interaction
- Keywords
- CD8+ T cell exhaustion, chronic viral infection, lymphocytic choriomeningitis virus, PD-1, inhibitory receptors, T cell receptor signaling, cytokine signaling, T cell metabolism, bioenergetics, T cell migration, transcription factors, T cell anergy, gene expression profiling, immunotherapy
- MeSH terms
- Animals, Cell Differentiation, Chronic Disease, Female, Flow Cytometry, Immunologic Memory, Lymphocyte Activation, Lymphocytic choriomeningitis virus, Mice, Inbred C57BL, Molecular Sequence Data, Phenotype, Virus Diseases, Gene Expression, Clonal Anergy, CD8-Positive T-Lymphocytes, Oligonucleotide Array Sequence Analysis, Gene Expression Profiling, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review